{
    "nctId": "NCT06592560",
    "briefTitle": "Asprosin in Breast Cancer",
    "officialTitle": "Diagnostic Value of Asprosin As a Biomarker in Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 84,
    "primaryOutcomeMeasure": "Diagnostic value of Asprosin as a biomarker in breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n-\n\nFemales aged (40 \u00b1 20 years) who did not receive any chemotherapy or surgical treatment and they will be divided as follow:\n\nGroup 1: healthy controls from healthy volunteers. Group 2: patients with benign breast lesions. Group 3: breast cancer patients.\n\nExclusion Criteria:\n\n* 1- Female patients with any other type of malignant or benign tumors. 2- Past history of chemotherapy or surgical treatment of cancer.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}